Bulletin
Investor Alert

Market Pulse Archives

Dec. 6, 2021, 7:05 a.m. EST

Becton Dickinson to name diabetes care spinoff 'embecta'

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Becton Dickinson & Co. (BDX)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

Becton Dickinson & Co. /zigman2/quotes/205527610/composite BDX +0.25% said Monday that the spinoff of its diabetes care business will be named "embecta." The previously announced spinoff, into an independent publicly traded company, is expected to be completed in the second quarter of 2022. Devdatt Kurdikar, who is president of the diabetes care business, will become chief executive officer of embecta. Becton Dickinson's stock, which was still inactive in premarket trading, has slipped 2.4% year to date, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -1.89% has rallied 20.8%.

/zigman2/quotes/205527610/composite
US : U.S.: NYSE
$ 264.63
+0.66 +0.25%
Volume: 1.69M
Jan. 21, 2022 4:00p
P/E Ratio
38.64
Dividend Yield
1.32%
Market Cap
$75.43 billion
Rev. per Employee
$269,973
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,397.94
-84.79 -1.89%
Volume: 3.20B
Jan. 21, 2022 4:52p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.